logo

Achieve Life Sciences Inc. (ACHV)



Trade ACHV now with
  Date
  Headline
9/13/2019 5:32:29 AM Achieve Life Sciences Says Final Phase 2b ORCA-1 Trial Data Presented
6/21/2019 5:32:45 AM Achieve Life Sciences To Present Phase 2b ORCA-1 Trial Data At SRNT-E 19th Annual Conference
6/11/2019 7:04:39 AM Achieve Life Sciences Announces Positive Results From ORCA-1 Dose-selection Trial Of Cytisinicline For Smoking Cessation
5/30/2019 5:34:30 AM US PTO Grants Achieve A Patent On Succinate Salt Of Cytisinicline And Use Thereof
5/15/2019 4:19:29 PM Achieve Life Sciences Q1 Loss/share $0.88 Vs. Loss $2.43 Year Ago
4/2/2019 5:33:23 AM Achieve Life Sciences Says DSMC Met On March 28, 2019 To Conduct Second And Final Safety Review Of ORCA-1 Trial
3/14/2019 4:14:37 PM Achieve Life Sciences Q4 Loss/share $0.55 Vs. Loss $3.17 Year Ago
2/22/2019 5:52:07 AM Achieve Says Final Data From Cytisinicline Phase I/II Multi-Dose PK/PD Clinical Study To Be Presented At SRNT Meeting
2/20/2019 5:31:12 AM Achieve Life Sciences Completes Enrollment In 254-Subject Phase 2b Trial Of Cytisinicline For Smoking Cessation
12/18/2018 5:32:31 AM Achieve Announces Update On Cytisinicline Clinical Development Program
  
 
>